Boost CBD Gummies Hair Growth: What the Evidence Shows and How They Fit Into Daily Wellness
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic CbdDermatologyHair LossMarketing…
Cannabis legalization spurs innovation, but not always in ways that benefit patients or public health
✦ New CED Clinical Relevance #65 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyResearchSafetyIndustry Why This Matters As cannabis legalization expands, clinicians must navigate an increasingly…
New Cannabis Group Will Help Ground Policy In Science And Patient Experience As …
WHY IT MATTERS: As federal rescheduling moves forward, organizations that center both clinical evidence and patient experience could directly shape whether patients gain broader, safer, and more affordable access to cannabinoid therapies. CLINICAL…
America Doesn’t Have A ‘Marijuana Problem,’ As NYT Claims—It Has a Cannabis Education …
WHY IT MATTERS: When media and policymakers frame cannabis use as a "problem" rather than an education gap, it slows the development of clinical programs, physician training, and insurance coverage that patients need to access safe, guided care. CLINICAL…
Takedown of Recent JAMA Cannabis Review
JAMA’s cannabis review is being treated like a verdict. It isn’t. This physician-led analysis explains what the science actually shows—and what it doesn’t—about cannabis risks, benefits, and clinical reality.
Cannabis and Psychosis: 5 Reasons This Study Doesn’t Say What You Think
A new study shows a 5x rise in cannabis-linked psychosis hospitalizations—but is it the plant, or the policy? This blog pulls back the curtain on what’s really behind the numbers: vague diagnoses, missing context, and a health system still catching up.…